SCHECHTER JONATHAN (CIK 1619259) reported 10 SEC Form 4 insider transactions across 3 companies over the past 18 months (most recent 2026-01-07). Recent activity: Buy PMCB (20,000 shares), Buy PMCB (20,000 shares), Buy PMCB (20,000 shares), Buy PMCB (150,000 shares), Sell PMCB (67,500 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-01-07 | PharmaCyte Biotech, Inc. (PMCB) | Director | Buy | 20,000 | $15,600 |
| 2026-01-07 | PharmaCyte Biotech, Inc. (PMCB) | Director | Buy | 20,000 | $15,800 |
| 2026-01-07 | PharmaCyte Biotech, Inc. (PMCB) | Director | Buy | 20,000 | $16,800 |
| 2025-12-12 | PharmaCyte Biotech, Inc. (PMCB) | Director | Buy | 150,000 | $0 |
| 2025-12-12 | PharmaCyte Biotech, Inc. (PMCB) | Director | Sell | 67,500 | $68,850 |
| 2025-11-17 | Oblong, Inc. (OBLG) | Director | Buy | 10,000 | $19,100 |
| 2025-09-17 | Oblong, Inc. (OBLG) | Director | Buy | 5,000 | $13,500 |
| 2025-09-16 | Oblong, Inc. (OBLG) | Director | Buy | 10,000 | $27,300 |
| 2025-07-02 | TAO Synergies Inc. (TAOX) | Director | Buy | 21,575 | $0 |
| 2025-07-02 | TAO Synergies Inc. (TAOX) | Director | Sell | 8,630 | $67,746 |
Source: SEC Form 4 filings · as of 2026-01-07